This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

ONE - Oneview Healthcare PLC

Jump to new
barney said:
ps I didn't get the "advisory email"

@Joe Blow ..... What is the story here??
Click to expand...

Some emails get lost in the black hole of the internet, filtered by ISPs or email clients, never to be seen again. Not sure why you didn't get it to be honest.

But yeah, it was research on ONE and was sent out as a paid promotion by S3 Consortium Pty Ltd. My understanding is that they do their research, find these companies that they deem to be undervalued by the market, and then take a large position. Following that they promote their research to stock market participants via various online channels, ASF being one, and hope the market catches on.

There has been quite a few of these emails go out with research on various stocks.
 
Yeah I'm happy to be kept in the loop about stocks to watch but I'd like to know the details behind it. Eg if it's a paid promotion like this was I'd like to know.

The shares have done amazingly well in this short time. If it's a pump and dump and you're going to sell now then you've done well. But it is promoted as a long term investment and we don't know where the shares will sit in say 6 - 12 months or evene 5 years time.

I'm just trying to ascertain whether I should take these recommendations seriously or not. This is the first one I've followed.

How have others done in the past does anyone know?
 
Joe Blow said:
Some emails get lost in the black hole of the internet, filtered by ISPs or email clients, never to be seen again. Not sure why you didn't get it to be honest.
Click to expand...

Thanks Joe. My email server might be filtering them into the junk bin. Will have a closer look. Cheers.
 
is there any hard news in this inconclusive conclusion to 04 Feb Business Update ?

• Partnerships for distribution are aligned to customer priorities for inpatient virtual care and will broaden our market reach
• New Oneview SaaS Sales Leaders in US and Australia
• Cloud has reinvigorated sales conversations with a number of major healthcare providers in the US and Australia
• Hospital budgets remain challenged, but this feels like the right product at the right time

Feeling good ... time for some Marketing
 
The above is what a German acquaintance of mine calls Buchstabensalat.

• Partnerships for alignment are distributed to inpatient care for customer virtual priorities and will market our broad reach
• New Oneview SaaS Sales Leaders in US and Australia
• Cloud has reinvigorated healthcare conversations with a number of major sales providers in the US and Australia
• Hospital budgets remain challenged, but this feels like the right time for the right product

It goes best with Mayo or Vinaigrette.

gg
 
Wrong question @Dona Ferentes. Should be - is there any news in this.
 
- this arrived in MY inbox

Share Purchases and the Company You Keep ... by Mark Story

One of the by-products of brokers trimming down their research teams in recent years is that stocks outside the ASX300 often don't get analysed. Sadly, if brokers don't analyse stocks, mainstream media is even less likely to cover them. This makes it doubly hard for mid-cap stocks, and virtually impossible for microcaps, to get the market's attention. If you want to know why only the large-caps get covered, take a closer look at the composition of the ASX.

While there are around 2185 stocks on the ASX as of today (March 25) the ASX300 comprises 6775 of the All Ords total 7022 points. In other words, around 90% of the stocks listed on the ASX barely ever move the market.

This means any stocks below the ASX300 with good stories – that could propel a share price – have to be a bit more inventive than relying on a release to the ASX or the media to penetrate the broader market.

As you would expect, most stocks pay PR firms to raise awareness of their corporate activity. Then there are companies that might pay for research designed to present the company in the most favourable possible light.

Beware spruikers and their undisclosed relationships
Scratch under the surface of today's 24-hour media machine, and what's now also lurking is the emergence of what's euphemistically referred to as the 'pump and dump' brigade. To the uninitiated, 'pump and dump' is the illegal practise of artificially spruiking a company's fortunes, typically to a microcosm of gullible followers, with the express purpose of pumping the price for a quick profit.

Australia is no stranger to small cap promotion sites, the most well-known being Hot Copper which currently generates revenue from commercial and corporate advertising and the provision of investor relation services. However, the recent incentivisation of small-cap promotion sites (aka digital marketing organisations) by having 'skin the game' for championing a company's fortunes, could be the first mutation of something resembling pump and dump taking a toe hold locally.

Hot Copper, by way of example, invests in its clients by taking equity positions of between $25,000 and $100,000, as part of equity capital raisings, which it calls its Capital Raise-Platinum Package.

Is this relationship a bit too cosy?
Another small-cap promotion site StocksDigital recently forged a relationship between Dublin-headquartered Oneview Healthcare PLC (ASX: ONE) and what's happened since is worth taking note of. Since the start of 2021, the share price of ONE is up a whopping 650%, and up over 1150% in the last 12 months.

Much of the healthcare technology company's share price fortunes can be attributed to a publicity deal it entered with S3 Consortium, (which trades as StocksDigital) on 12 March. To summarise, in return for sharing research, commentary and investment advice on ONE with its community of investors for an initial 18 months, StocksDigital receives 6,250,000 CHESS depositary interests (CDIs) over fully paid ordinary shares.

This deal effectively avoids ONE having to pay $375,000 in fees for the company's publicity services. When justifying the deal, Oneview Healthcare highlighted the need to take the initiative in the absence of any coverage of the company. The company also maintained that StocksDigital's media coverage would strengthen its balance sheet.

Additional to its end of the agreement, StocksDigital and other strategic investors in its network invested $1 million into Oneview Healthcare. In return, 16.6 million CDIs were allotted from ONE to the participating investors. The company set the offer price at 6 cents apiece – which was a discount of 18.9% on the volume-weighted average price of CDIs over the prior 5 trading days. Oneview plans to use this capital to promote of its new cloud platform.

StocksDigital actively promotes the stocks within its stable via a series of email advertisements under several different brands, these include www.wise-owl.com, and www.nextinvestors.com.

StocksDigital founder Damian Hajada told Share Café that the OneView deal is one of many where scrip is involved. But what distances the company from the 'pump and dump' brigade, adds Hajada is the AFSL licence under which its three funds operate. As a result, the company is prevented from trading for seven to ten days after its media coverage comes out.

"We're no different from a VC fund that lists its investment, and see ourselves as more fund manager than media company these days," says Hajada. "Out of the 400 investments we're shown annually, StocksDigital invests in around 10 and the disclosure statements that are all over our websites should make it clear what positions we take within the companies we write about."

Poacher becomes gamekeeper
There are many levels on which this agreement could be construed as questionable. Firstly, it assumes StocksDigital and the market at large is aware of the media relationship with Oneview Healthcare.

Secondly, there's the danger that the share price is being driven up within a thin vein of StocksDigital's 'true believers'. But in fairness, StocksDigital is not alone in this regard. For example, Intelligent Investor likes to recommend to its readers (many of whom invest in its funds) small caps its thinks have big futures. But given the tight liquidity in these stocks, even thin trading by the Intelligent Investor cohort can also give the share price a material nudge up (or down).

What's going to amplify the buying into Oneview Healthcare by the StocksDigital cohort is the extreme poor liquidity into the stock. For example, while the stock has a market cap a little over $100 million (with approximately 424 million shares outstanding), 76.9% is tightly held by the top 20 shareholders, which means there's only around $20 million in free-float.

Does the regulator care?
While the regulator (ASIC) has in the past appeared relatively toothless when it comes to calling out borderline practises, it has become increasingly concerned about 'social trading' contributing to herd momentum in speculative stocks. Adding to ASIC's concerns is the clear evidence that rookie investors are increasingly playing in the smaller-end share market sandpit, typically well outside the ASX 300 and deep into penny-hopeful territory.

To highlight the menacing impact of social trading, ASIC noted that between April 6 and June 12 2020 there were 255 ASX-listed companies where share prices doubled, 70 companies that tripled and 29 that quadrupled. Equally revealing, retail investors accounted for 80% of trades of these stocks, despite comprising just 16% of broader market activity.

But what's even more incriminating is that of these 255 ASX listed shares, ASIC also noted 80% had negative earnings in FY2019, while the remaining 20% had relatively high price-to-earnings (P/E) ratios (averaging around 55).,....
 
ONE today announced the launch of CXP Cloud Enterprise, the world’s first and only cloud based care experience platform. Deployed on Microsoft Azure, this platform enables health systems to quickly adopt technology for engaging patients, reducing non-clinical demands on care teams and optimising clinical and operational effectiveness. This comes at a critical time to meet the demand for digital services driven by the pandemic.



I guess they said they would tilt towards this, and now it is official. Whether CXP is the optimum care experience outcome remains to be seen but being first will give some advantage.

Market rewarding with a 25% lift
 
Chart update: Just remembered I should update this thread.
Comments in the chart are from Tech/a at the end of May.
ONE had a great month in May and has continued on it's journey upwards so far this month, so it deserved a fresh chart here.

 
You must log in or register to reply here.

Similar threads

DOC - Doctor Care Anywhere Group PLC
Replies
7
Views
2K
Dona Ferentes
EMD - Emyria Limited
Replies
5
Views
2K
noirua
NXL - Nuix Limited
3 4 5
Replies
89
Views
19K
Dona Ferentes
BMT - Beamtree Holdings
2 3
Replies
53
Views
12K
Dona Ferentes
SHG - Singular Health Group
Replies
12
Views
4K
noirua
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more...